Ani Pharmaceuticals (ANIP) FCF Margin Growth (5y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,157.00 |
| Mar 31, 2026 | -15,628.00 |
| Dec 31, 2025 | 3,062.00 |
| Sep 30, 2025 | 2,700.00 |
| Jun 30, 2025 | -1,264.00 |
| Mar 31, 2025 | 1,689.00 |
| Dec 31, 2024 | 580.00 |
| Sep 30, 2024 | -4,161.00 |
| Jun 30, 2024 | 58.00 |
| Mar 31, 2024 | -1,126.00 |
| Dec 31, 2023 | -1,199.00 |
| Sep 30, 2023 | 1,419.00 |
| Jun 30, 2023 | 441.00 |
| Mar 31, 2023 | -3,139.00 |
| Dec 31, 2022 | -5,197.00 |
| Sep 30, 2022 | -1,632.00 |
| Jun 30, 2022 | -1,619.00 |
| Mar 31, 2022 | -4,738.00 |
| Dec 31, 2021 | -5,145.00 |
| Sep 30, 2021 | -996.00 |